CD63 and COVID-19: In line with this result, the majority of the EVs obtained from severe COVID-19 patients were smaller than 150 nm (t test p = 0.0158 Figure 2c) and expressed significantly higher amounts of the exosome marker CD63 (expressed as a ratio of actin) (Figure 2d, Supplementary Figure SM1a–c).